News

Update on the 2025 call topics - Health Cluster Horizon Europe

Published on | 2 weeks ago

Programmes Health

You may have noticed that call topics for 2025 are not yet available on the Funding & Tenders Portal. This is due to ongoing preparatory work. Adoption will be the earliest in April 2025. To stay ahead, consider reading a draft version.

A bit on the process

A work programme is typically drafted in stages. It begins with setting priorities, after which topics are drafted in collaboration between the Commission, expert groups and stakeholders. This initial phase is followed by consultations with Member States and advisory bodies. Drafts undergo subsequently several reviews and revisions before their final adoption. Once a work programme is adopted, the call topics are published on the Funding & Tenders Portal.

Timing for WP 2025

The procedure for consultation of the stakeholders was finalised end of 2024. Currently, an Inter-Service Consultation is ongoing. This will lead to a version that is expected to be adopted by the Programme Committee in March 2025, so that the Work Programme can finally be adopted in April 2025.

It is reasonable to expect that most of the the call topics will have submission deadlines the earliest by the end of the Summer. Currently 18 September 2024 (for single stage & first-stage applications) and 16 April 2026 (for second stage applications of two-stage topics) circulate as tentative closing dates.

Start preparing

The best way to prepare is by reading the draft work programme. Even though these are not final documents and changes may occur until official publication, they do give a good indication on what to expect.

The easiest way forward is to download the version from December 2024 on Science Business of the Health WP 2025. More recent versions might be available with the Programme Committee delegates. Stakeholders located in Flanders can turn to the Programme Committee delegates of the Department of Economy, Science and Innovation with questions regarding the Work Programme during this preparation phase.

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Latest News

1528 articles available search in articles 

Testimonial

image of Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.